PPH Holdings — VanEck Pharmaceutical ETF
All 26 reported holdings of VanEck Pharmaceutical ETF (PPH) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co | 18.70% | $240.48M |
| Novartis AG | 10.76% | $138.39M |
| Merck & Co Inc | 9.68% | $124.48M |
| Pfizer Inc | 5.23% | $67.22M |
| Novo Nordisk A/S | 4.81% | $61.85M |
| Sanofi SA | 4.73% | $60.80M |
| Bristol-Myers Squibb Co | 4.62% | $59.47M |
| Gsk PLC | 4.58% | $58.86M |
| AstraZeneca PLC | 4.40% | $56.57M |
| Johnson & Johnson | 4.34% | $55.78M |
| McKesson Corp | 4.24% | $54.48M |
| AbbVie Inc | 4.12% | $52.97M |
| Cencora Inc | 3.74% | $48.05M |
| Zoetis Inc | 3.47% | $44.68M |
| Haleon PLC | 3.22% | $41.39M |
| Takeda Pharmaceutical Co Ltd | 3.15% | $40.47M |
| Teva Pharmaceutical Industries Ltd | 2.83% | $36.39M |
| State Street Global Advisors | 1.89% | $24.27M |
| Viatris Inc | 0.90% | $11.55M |
| Jazz Pharmaceuticals PLC | 0.80% | $10.29M |
| Axsome Therapeutics Inc | 0.51% | $6.61M |
| Elanco Animal Health Inc | 0.35% | $4.55M |
| Corcept Therapeutics Inc | 0.22% | $2.86M |
| Bausch Health Cos Inc | 0.10% | $1.33M |
| Organon & Co | 0.10% | $1.26M |
| Perrigo Co PLC | 0.07% | $904.08K |